DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Tina Tian, Medical Oncology Registrar, Hawke's Bay Hospital, Hastings, New Zealand, 2013.
POEMS syndrome is a rare multisystem disorder. POEMS stands for:
The cause of POEMS syndrome is not well understood. It is associated with a chronic overproduction of pro-inflammatory cytokines (small molecules that act as messengers between cells to promote inflammation). These include IL-1b, IL6, TNFα and vascular endothelial growth factor (VEGF – a powerful vasodilator that may cause leaky blood vessels).
POEMS syndrome is rare, with only a few hundred cases described in the medical literature. However, it may be underreported due to being under-recognised. Many of thes cases are from Japan.
POEMS syndrome is 2.5 times more common in men than in women. It also presents at a younger age in men, most commonly in their 40s and 50s.
A common initial presentation of POEMS syndrome is with progressive weakness and swelling of the peripheries. Clinical manifestations vary depending on the organ systems involved.
Peripheral neuropathy (disorder of peripheral nerves) is often prominent, causing weakness in the feet and later in the arms. In more than half of patients, the weakness is severe, so that they are unable to climb stairs, get up from a seated position, or grip objects. Patients are often eventually confined to a wheelchair.
POEMS syndrome can also cause reduced sensation. Pinprick, vibration and sense of position (proprioception) are affected the most, whereas temperature and pain sensation usually stay normal.
Cranial and autonomic nerves are not affected in POEMS syndrome. However, vision may be affected because of papilloedema (swelling of the optic disc).
Organomegaly (enlargement of internal organs) is present in up to 50% patients and is generally mild. Most commonly affected organs are:
Most patients with POEMS syndrome have endocrinopathy (disorder of endocrine glands), often with multiple abnormalities.
Hypogonadism is the most common abnormality. Low testosterone and elevated oestrogen levels have been reported, as have impotence and enlarged breasts (gynaecomastia) in men and amenorrhoea (absence of menstrual bleeding) in women.
Other reported endocrine abnormalities in POEMS syndrome include:
The detection of monoclonal immunoglobulins (antibodies) confirm the presence of a monoclonal plasma cell proliferative disorder. Investigations may include serum immunoglobulins and electrophoresis, urinary Bence-Jones proteins, bone or bone marrow biopsy.
Darkened skin colour (hyperpigmentation) has been seen in about 50–90% patients with POEMS syndrome. This is most commonly diffuse but can be localised. It most frequently affects the extensor surfaces, neck, axilla and back. There is an increase in melanin production without an increase in the number of melanocytes, a process similar to that seen in Addison disease.
Scleroderma-like skin thickening and tightening has been reported in 25–80% of patients.
Hypertrichosis (excessive hair growth) has been noted in around 25–80% of patients, most often resulting in coarse black hair over face, limbs and chest.
Other skin problems may include:
POEMS syndrome is not usually associated with mucous membrane involvement.
POEMS syndrome may also cause:
When a monoclonal gammopathy is found, other diagnoses that should be considered include:
The diagnosis of POEMS syndrome should be considered in patients with peripheral neuropathy of unknown cause plus a plasma cell disorder. The Mayo Clinic diagnostic criteria for POEMS syndrome consists of 5 major criteria, and 6 minor criteria. To diagnose POEMS, you need:
|Mandatory major criteria||Major criteria||Minor criteria|
*Due to the common nature of diabetes and hypothyroidism in the general population, these disorders are not sufficient to fulfil minor diagnostic criteria for POEMS.
Suggested investigations depend on the clinical picture and may include the following:
POEMS syndrome is a chronic disease. The median survival is around a decade (8-14 years), which is 3 times longer than patients with multiple myeloma. However, many patients are bedridden due to neuropathy (50%).
Shorter survival is associated with nail clubbing and extravascular fluid overload. The most common causes of death are:
As POEMS syndrome is rare, there are no standard treatments or randomised controlled trials to inform us which treatment is most effective. Management depends on treatment of the underlying plasma cell disorder and may include radiation therapy, chemotherapy or haematopoietic cell transplantation.
Around 75% of patients have some response to treatment, and VEGF levels (if available) can be used to follow response.
See the DermNet NZ bookstore.
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.